Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Operating Margin (2016 - 2025)

Historic Operating Margin for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to 325.44%.

  • Editas Medicine's Operating Margin rose 1073237400.0% to 325.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 428.71%, marking a year-over-year decrease of 586800.0%. This contributed to the annual value of 777.22% for FY2024, which is 5606700.0% down from last year.
  • Per Editas Medicine's latest filing, its Operating Margin stood at 325.44% for Q3 2025, which was up 1073237400.0% from 1440.58% recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Operating Margin ranged from a high of 39.9% in Q4 2023 and a low of 136952.38% during Q3 2022
  • Its 5-year average for Operating Margin is 15270.04%, with a median of 940.09% in 2023.
  • As far as peak fluctuations go, Editas Medicine's Operating Margin crashed by -1363189600bps in 2022, and later soared by 1360122900bps in 2023.
  • Quarter analysis of 5 years shows Editas Medicine's Operating Margin stood at 333.71% in 2021, then plummeted by -191bps to 970.72% in 2022, then surged by 96bps to 39.9% in 2023, then plummeted by -282bps to 152.24% in 2024, then crashed by -114bps to 325.44% in 2025.
  • Its last three reported values are 325.44% in Q3 2025, 1440.58% for Q2 2025, and 1635.1% during Q1 2025.